You Can Help!

The Coalition for Methadone Choice is attempting to
prevent Mayor Giuliani from ‘detoxing’ more than 2000 patients and threatening
treatment for thousands more.

We are looking for:

               
Methadone maintenance patients to participate in public education and/or
lobbying.


               
Patients at city-run programs to join in legal efforts to save their treatment.


               
Anyone who has any factual information about the city’s plans.


 

Please call Holly Catania at 212-548-0165

Or write: [email protected]

 

Back
to News

Similar Posts

  • NAMA Policy Statement: Blind Dosing and Patient Dignity

    Admin 06/10/2023

    Methadone maintenance treatment has been the most effective treatment for addiction to heroin resulting the cessation of heroin use and criminal behavior. Prior to the development of methadone maintenance treatment over 28 years ago narcotic addiction was considered incurable and a behavioral disorder under the control of law enforcement. Drs. Dole and Nyswander brought the…

  • Stop Methadone Ignorance

    Admin 08/26/2022

    Six Steps to Zero Deaths Never take a prescription painkiller unless it is prescribed to you. Everyone responds differently to pain medications. What is safe for one person may not be safe for another. Do not take pain medicine with alcohol. Never mix the two, it is a dangerous combination that can be deadly. Alcohol…

  • Recertification

    Admin 04/06/2021

    Recertify for Your Medication Assisted Treatment Advocate (CMA) About Recertification We have had many persons who are certified contact us about recertification. Previously the only way to recertify was to take the training again. There have been some CMAs who saw their certification as so valuable that they have taken the training again. Steps to…

  • Food and Drug Administration Alert

    Admin 08/11/2022

    T01-15 April 20, 2001 Print Media: 301-827-6242 Broadcast Media: 301-827-3434 Consumer Inquiries: 888-INFO-FDA FDA Warns About Orlaam The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With Addiction…

  • Publication Index

    Admin 03/18/2022

    FOR IMMEDIATE RELEASE: October 9, 2002 NIDA Contact: Michelle Person 301-443-6245 SAMHSA Contact: Leah Young 301-443-8956 NIDA Research and SAMHSA Physician Training Combine to Put Care for Opiate Dependence in Hands of Family Doctor. Buprenorphine, a new medication developed through more than a decade of research supported by the National Institute on Drug Abuse (NIDA),…